STAT+: Pharmacists can make shortage drugs, but at what cost?
Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in…
Category: Generics
.jpg)
STAT+: 6 ways the government could help address drug shortages, including in cancer
WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing…
STAT+: White House drug shortage task force held rare in-person meeting with industry
WASHINGTON — A new White House task force on drug shortages held a rare in-person…
STAT+: House GOP offers new plan to stem drug shortages, including cancer drug shortages
WASHINGTON — House Republicans have drafted drug-shortage legislation that differs significantly from the approach Democrats…
STAT+: Senate panel passes a suite of drug pricing bills — but fails to advance one major PBM reform
WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at…
STAT+: Senate hashing out policy details on generics, PBMs, insulin
WASHINGTON — Senators are slightly delaying their latest legislative push on health care, but as they…
Opinion: Biosimilars competition helps patients more than generic competition
Much of the current drug-pricing agenda proposed by President Biden and by Congress is based…
STAT+: Dozens of generic makers and pharmacies won’t face lawsuits over Zantac and cancer risks
A federal court judge dismissed all claims against dozens of generic manufacturers and retailers in…
STAT+: Washington may become the second state to distribute its own generic drugs
A bill moving through the Washington legislature may make the state only the second in…
STAT+: To delight of generic drug makers, federal appeals court tosses controversial ‘skinny labeling’ decision
In a surprising move, a federal appeals court panel may revisit a controversial decision that…
STAT+: U.S. drug prices were more than double those in dozens of countries in 2018
As debate intensifies over the cost of medicines, a new analysis found that prescription drug…
STAT+: The CEO of Mark Cuban’s generics company talks drug prices, manufacturing, and his famous boss
In a surprise move, Mark Cuban last week announced plans to enter the generic drug…
STAT+: Mark Cuban wades into the generic drug shark tank with a new company
Mark Cuban turns down new business opportunities on Shark Tank by declaring “I’m out!” But…
STAT+: Generic drug makers fear a ‘skinny labeling’ court ruling will pose a huge threat
An arcane regulatory term known as skinny labeling may have a funny ring to it,…
STAT Plus: Supreme Court deals a series of blows to generic drug companies
It’s a bad run for generic drug companies at the Supreme Court. The court on…
Opinion: It’s time to bring generic drug manufacturing back to the U.S.
In a hearing Tuesday afternoon on Capitol Hill, policymakers will consider repatriating America’s drug supply…